Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.
Study Goal
The researchers aimed to determine how saturated fatty acids (SFA) and polyunsaturated fatty acids (PUFA) affect liver fat accumulation and ceramide levels in overweight and obese individuals.
Results Summary
SFA increased liver fat content and serum ceramides, while PUFA prevented liver fat accumulation and reduced ceramides. The adverse metabolic effects of SFA were reversed by calorie restriction.
Population
Overweight or obese men and women (n = 61).
Effective Dosage
Not specified (muffins high in palm oil [SFA] or sunflower oil [PUFA] added to habitual diet).
Duration
8 weeks of overfeeding, followed by 4 weeks of caloric restriction.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Saturated fatty acid (SFA)-enriched diet (overfeeding) | increase | liver fat content | overweight and obese humans | 50% relative increase | markedly induced | #1 |
Saturated fatty acid (SFA)-enriched diet (overfeeding) | increase | liver enzymes | overweight and obese humans | - | induced | #2 |
Saturated fatty acid (SFA)-enriched diet (overfeeding) | increase | atherogenic serum lipids | overweight and obese humans | - | induced | #3 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | no change | liver fat | overweight and obese humans | - | did not increase | #4 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | no change | liver enzymes | overweight and obese humans | - | did not increase | #5 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | no change | blood lipids | overweight and obese humans | - | did not cause any adverse effects on | #6 |
Saturated fatty acid (SFA)-enriched diet (overfeeding) | no change | visceral fat | overweight and obese humans | - | had no differential effect on the accumulation of | #7 |
Saturated fatty acid (SFA)-enriched diet (overfeeding) | no change | pancreas fat | overweight and obese humans | - | had no differential effect on the accumulation of | #8 |
Saturated fatty acid (SFA)-enriched diet (overfeeding) | no change | total body fat | overweight and obese humans | - | had no differential effect on the accumulation of | #9 |
Saturated fatty acid (SFA)-enriched diet (overfeeding) | increase | circulating ceramides | overweight and obese humans | - | increased | #10 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | decrease | circulating ceramides | overweight and obese humans | - | reduced | #11 |
Calorie restriction | decrease | adverse metabolic effects of SFA | overweight and obese humans | - | reversed | #12 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | decrease | liver fat accumulation | overweight individuals | - | prevents | #13 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | decrease | ceramides | overweight individuals | - | reduces | #14 |
Polyunsaturated fatty acid (PUFA)-enriched diet (overfeeding) | decrease | hyperlipidemia | overweight individuals | - | reduces | #15 |
CONTEXT: Saturated fatty acid (SFA) vs polyunsaturated fatty acid (PUFA) may promote nonalcoholic fatty liver disease by yet unclear mechanisms. OBJECTIVE: To investigate if overeating SFA- and PUFA-enriched diets lead to differential liver fat accumulation in overweight and obese humans. DESIGN: Double-blind randomized trial (LIPOGAIN-2). Overfeeding SFA vs PUFA for 8 weeks, followed by 4 weeks of caloric restriction. SETTING: General community. PARTICIPANTS: Men and women who are overweight or have obesity (n = 61). INTERVENTION: Muffins, high in either palm (SFA) or sunflower oil (PUFA), were added to the habitual diet. MAIN OUTCOME MEASURES: Lean tissue mass (not reported here). Secondary and exploratory outcomes included liver and ectopic fat depots. RESULTS: By design, body weight gain was similar in SFA (2.31 ± 1.38 kg) and PUFA (2.01 ± 1.90 kg) groups, P = 0.50. SFA markedly induced liver fat content (50% relative increase) along with liver enzymes and atherogenic serum lipids. In contrast, despite similar weight gain, PUFA did not increase liver fat or liver enzymes or cause any adverse effects on blood lipids. SFA had no differential effect on the accumulation of visceral fat, pancreas fat, or total body fat compared with PUFA. SFA consistently increased, whereas PUFA reduced circulating ceramides, changes that were moderately associated with liver fat changes and proposed markers of hepatic lipogenesis. The adverse metabolic effects of SFA were reversed by calorie restriction. CONCLUSIONS: SFA markedly induces liver fat and serum ceramides, whereas dietary PUFA prevents liver fat accumulation and reduces ceramides and hyperlipidemia during excess energy intake and weight gain in overweight individuals.